eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2010
vol. 7
 
Share:
Share:
abstract:

Badania kliniczne i doświadczalne w chorobach serca, płuc i naczyń
New guidelines of the American Diabetes Association (ADA) emphasize the diagnostic and prognostic value of glycated haemoglobin: reasons for satisfaction for cardiac surgeons and the operated patients

Przemysław Trzeciak
,
Jerzy Foremny
,
Marta Wróbel
,
Mirosława Herdyńska-Wąs
,
Tomasz Hrapkowicz
,
Aleksandra Szymborska-Kajanek
,
Paweł Nadziakiewicz
,
Piotr Knapik
,
Ewa Kucewicz
,
Krzysztof Strojek
,
Marian Zembala

Kardiochirurgia i Torakochirurgia Polska 2010; 7 (2): 180–184
Online publish date: 2010/06/30
View full text Get citation
 
The latest published guidelines of the American Diabetes Association (ADA) for the first time introduce the assessment of glycated haemoglobin percentage (HbA1c) as a tool in diagnosing advanced diabetes. According to the guidelines, diabetes may be diagnosed when the HbA1C value is equal to or greater than 6.5%. The guidelines still include the diagnostic criteria based on the fasting glycemic level (≥ 126 mg/dl) and glycemic results two hours after oral administration of 75 γ of glucose (≥ 200 mg/dl).

The work outlines the preparation of diabetic patients with elevated glycated haemoglobin, qualified for cardiac surgeries. The different courses of action in patients qualified for elective and non-elective surgery are demonstrated, and the rules on incorporating insulin into the therapy are discussed. Furthermore, the article describes the schedule of intravenous continuous insulinotherapy in the perioperative period, implemented in patients undergoing cardiac surgeries at the Silesian Centre for Heart Diseases in Zabrze since 2002.
keywords:

glycated haemoglobin, diabetes, intravenous insulin therapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.